Skip to content
Independent home-inspection guidance. We are not affiliated with the prior occupant of this domain.
Find an inspector

Mold Toxicity Testing: What Homeowners Need to Know in 2026

By InspectandTest Editorial Team Published May 11, 2026

We may earn commission from links on this page. Lead-form submissions are forwarded to local inspector partners. How we research and review.

Photo via Unsplash by Beth Macdonald

“Mold toxicity testing” can mean very different things depending on whether the person asking is talking about their body or their home. Some tests measure mold exposure markers in human biological samples (urine, blood). Others quantify mold in the environment (dust, air, surfaces). Each has different evidence behind it, different costs, and different limits. This guide walks through what each category of test claims to measure, what federal health agencies actually say about interpretation, and where the environmental side of the question is where home inspection fits. The information here summarizes published guidance from CDC, EPA, NIEHS, ATSDR, and CDPHE current as of 2026; nothing here is medical advice β€” physicians remain the right resource for symptoms, diagnosis, and treatment decisions. Background on the methodology we follow on the environmental side is available on our methodology page.

Is this mold, asbestos, or water damage? Get a free instant screen

Upload a clear photo of the suspect area. You'll get an instant AI screening opinion and what to do next. This is screening guidance, not a professional determination.

Screening guidance only. AI can be wrong. Confirm asbestos, mold type, or lead with lab testing or a licensed professional before acting.

Two very different questions

The first question β€” “is something growing in my home that I’m being exposed to?” β€” is an environmental one. It is answered with visual inspection, moisture data, and laboratory analysis of air, surface, or dust samples from the building. The second question β€” “am I experiencing health effects from mold exposure?” β€” is a medical one. It is answered by a physician evaluating symptoms in the context of exposure history, laboratory studies, and differential diagnosis. The two questions overlap but require different tools.

Confusing them is the source of much of the confusion in the mold testing market. A urine mycotoxin panel does not tell you whether your basement has Stachybotrys; an air cassette in your basement does not tell you whether your headaches are caused by mold.

Tests that measure exposure markers in the body

Urine mycotoxin panels

Several commercial labs offer urine panels that report concentrations of specific mycotoxins β€” ochratoxin A, aflatoxins, trichothecenes, and others. These are sold direct-to-consumer for $250 to $500 per panel. The CDC’s position is that the clinical utility of urine mycotoxin testing for diagnosing mold illness in the general population is not established. The American Academy of Pediatrics and the American College of Medical Toxicology have both raised concerns about over-interpretation of these panels.

What homeowners should know: results can be influenced by dietary exposure (mycotoxins are found in stored grains, coffee, dried fruit), and reference ranges from these labs are not derived from population studies the way standard clinical labs are. Discuss any panel results with a physician.

Blood antibody testing

Serum IgE testing for specific mold antigens is a standard allergy diagnostic. Mold allergy is well-characterized, and an allergist can test for sensitivity to Alternaria, Cladosporium, Aspergillus, and other species. This is different from “mycotoxin illness” claims. Allergy testing answers a focused question about IgE-mediated reactions.

The NIEHS publishes accessible plain-language information on mold and health, including what allergy testing measures and what it does not. Homeowners with persistent respiratory symptoms in a building with known mold should discuss allergy testing with a physician.

Other in-body tests

Tests marketed under labels like “TGF-beta,” “C4a,” “VEGF,” or “MARCoNS” appear in some integrative practitioner protocols. The evidence base for these as mold-illness diagnostics is contested and is not endorsed by CDC, EPA, or major specialty societies. Homeowners considering these tests should discuss them with their physician of record and read about each marker’s general use in medicine before paying out of pocket.

Tests that measure mold in the environment

Air sampling (spore traps)

The most common environmental mold test is a spore trap such as the Air-O-Cell cassette. A small pump draws a measured volume of air through a sticky slide that captures airborne particles. The AIHA-LAP-accredited lab identifies and counts spores per cubic meter, reporting by genus. A defensible protocol pairs indoor samples with an outdoor control taken at the same time.

Limits: a single grab sample at one moment in time is noisy data. Spore counts swing with HVAC operation, foot traffic, weather, and time of day. The AIHA and ACGIH recommend interpretation by a qualified industrial hygienist who places the numbers in context with visual findings and moisture history.

Surface and bulk sampling

Tape lifts, swabs, and bulk samples of suspected growth materials are analyzed by direct microscopy or culture. These confirm what is present on a specific surface rather than estimating airborne exposure. They are most useful as part of a sampling plan that ties findings to a specific assembly or moisture source.

ERMI and HERTSMI-2 dust testing

The Environmental Relative Moldiness Index quantifies DNA from 36 mold species in settled dust using species-specific quantitative PCR. EPA researchers developed ERMI in the mid-2000s for research applications. EPA’s official position is that ERMI is a research tool and has not been validated as a stand-alone remediation benchmark for individual homes. Several remediation companies market it as a clinical diagnostic regardless.

HERTSMI-2 is a 5-species subset derived from ERMI, originally proposed for re-occupancy decisions. Like ERMI, it remains a screening tool rather than a validated diagnostic.

What environmental testing can and cannot tell you

Environmental testing answers: “Is there elevated mold activity in this building compared to an outdoor reference, and where might it be?” It does not answer: “Is this affecting my health?” That second question belongs to the physician, who integrates environmental data with clinical findings. Our companion guide on mold toxicity test walks through additional environmental options.

Where federal health agencies stand

The CDC, EPA, and NIEHS all converge on a few points. Damp indoor environments are associated with increased respiratory symptoms, asthma exacerbations, and upper respiratory tract problems. The strength of evidence for specific “mold toxicity” syndromes outside of allergy, asthma, and infections in immunocompromised patients is more limited. The Institute of Medicine’s 2004 report “Damp Indoor Spaces and Health” remains a foundational reference; subsequent reviews from the World Health Organization and ATSDR are consistent.

What this means practically: take damp indoor environments seriously, dry them out, clean visible mold, and address moisture sources. Use the environmental data to drive cleanup decisions. Use a physician for symptom evaluation.

Costs across the testing landscape

Urine mycotoxin panels: $250 to $500 per panel, usually out-of-pocket. Blood IgE allergy testing: $50 to $200 per allergen, often covered by insurance when ordered by a physician. Spore trap air sampling: $50 to $100 per cassette including lab, typically $300 to $500 for a residential project. ERMI dust analysis: $250 to $350 per sample.

Total project cost varies. A focused environmental assessment with three air cassettes and one outdoor control typically runs $500 to $900 for the inspector’s labor plus the lab pass-through. Compare that to multi-thousand-dollar testing panels marketed to homeowners worried about toxicity, and the environmental side is usually a more cost-effective first step toward identifying what to fix.

Choosing the right next step for your situation

If the question is “should I clean up something visible in my home,” EPA guidance is direct: clean visible mold under 10 square feet using standard household methods; hire a remediator for larger jobs; address the moisture source.

If the question is “is there hidden growth I’m being exposed to,” environmental sampling by a credentialed inspector is the right tool β€” air cassettes, surface samples, moisture mapping, thermal imaging. The companion mold poisoning test guide goes deeper on the question.

If the question is “are my symptoms caused by mold,” start with your physician. Bring documented environmental data if it exists. Allergy testing, pulmonary function tests, and a careful history are standard tools. Decline to interpret panels yourself β€” that is what the physician is for.

Front Range context

Colorado’s CDPHE indoor air quality program publishes general guidance for residents and recommends starting with visual inspection and moisture management rather than reflexive sampling. For Front Range homeowners, that approach is consistent with the broader federal framework. The environmental side of the question β€” does this home have a moisture problem, and where? β€” is the side a home inspection actually addresses.

References

The environmental side of the question is where home inspection comes in. Front Range homeowners who want a credible assessment of moisture and mold in their building can connect with our team through the contact page.